Singapore Pharmaceuticals and Healthcare Report Q2 2015

Business Monitor International
February 18, 2015
132 Pages - SKU: BMI5470841
Countries covered: Singapore

Singapore Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational risks and the government's support for the industry. Thepharmaceutical industry has been a key pillar of the country's economy and we believe its importance willcontinue to grow as traditional drivers such as electronic manufacturing slow.

Headline Expenditure Projections

Pharmaceuticals: SGD1.041bn (USD822mn) in 2014 to SGD1.097bn (USD836mn) by 2015; +5.4% inlocal currency terms and +1.7% in USD terms.

Healthcare: SGD19.31bn (USD15.24bn) in 2014 to SGD20.97bn (USD15.97bn) by 2015; +8.6% inlocal currency terms and +4.8% in USD terms.



More Prescription Drugs reports by Business Monitor International

Tanzania Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q2 2015BMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion ofthe country's National Health Insurance ...
Poland Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Poland Pharmaceuticals and Healthcare Report Q2 2015BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; anynegative economic developments will have an ...
Peru Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2015BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to ...
New Zealand Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q2 2015BMI View: Despite policy initiatives designed to increase the pace of generic penetration, high latentdemand for branded pharmaceuticals ...
See all reports like this >>

More Singapore Prescription Drugs reports

Singapore Pharmaceutical Industry Report - 2014 by Emerging Markets Direct Reports
Singapore Pharmaceutical Industry Report - 2014This report profiles Singapore’s pharmaceutical industry, analyzing sector size and performance, competitive landscape, recent development in the industry as well ...
Singapore Healthcare Industry 2H12 by Emerging Markets Direct Reports
Singapore: Healthcare covers the Asia-Pacific overview, general overview of Singapore, and Singapore healthcare industry including social development and healthcare services. It also covers the market ...
Antibiotics Market in Singapore to 2016 by Global Research & Data Services Oy
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market ...
The Pharmaceutical Market: Singapore by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!